AVITA Medical announces departure of CFO Michael Holder and COO Kathy McGee, appoints Sean Ekins as interim CFO

AVITA Medical, Inc.

CFO Michael Holder and COO Kathy McGee leaving Avita Medical effective Jan 19, 2023.
Sean Ekins, SVP of Finance, appointed interim CFO; company will search for permanent CFO.
COO role discontinued; product development, operations, regulatory report directly to CEO James Corbett.
Holder and McGee receive severance: 12 months base salary, health benefits, stock acceleration; McGee also gets 2022 bonus of $164,140.
Company will report Q4 2022 earnings on Feb 23, 2023, and provide revenue guidance for Q1 and full year 2023.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kathy McGee

Chief Operating Officer

RCEL · AVITA Medical, Inc.

Effective: 2023-01-19
Filed: January 20, 2023, 6:59 PM ET

Michael Holder, the Company’s Chief Financial Officer, and Kathy McGee, the Company’s Chief Operating Officer, are leaving the organization.

Departed

Michael Holder

Chief Financial Officer

RCEL · AVITA Medical, Inc.

Effective: 2023-01-19
Successor: Sean Ekins
Filed: January 20, 2023, 6:59 PM ET

Mr. Holder’s responsibilities as the Company’s principal financial officer and principal accounting officer will transition to Mr. Sean Ekins, as Interim Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kathy McGee departed as Chief Operating Officer at AVITA Medical, Inc..

Action: leaving
Role: Chief Operating Officer

Exact text from the filing

Michael Holder, the Company’s Chief Financial Officer, and Kathy McGee, the Company’s Chief Operating Officer, are leaving the organization.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael Holder changed role as Chief Financial Officer at AVITA Medical, Inc..

Action: transitioning
Role: Chief Financial Officer

Exact text from the filing

Mr. Holder’s responsibilities as the Company’s principal financial officer and principal accounting officer will transition to Mr. Sean Ekins, as Interim Chief Financial Officer, effective immediately.

View on SEC.gov

AVITA Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-011170

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.